SAN

73.44

+0.45%↑

ARGX

767.6

+1.21%↑

SHL.DE

34.13

-0.32%↓

PHIA

23.38

+0.04%↑

FRE

39.68

+1.38%↑

SAN

73.44

+0.45%↑

ARGX

767.6

+1.21%↑

SHL.DE

34.13

-0.32%↓

PHIA

23.38

+0.04%↑

FRE

39.68

+1.38%↑

SAN

73.44

+0.45%↑

ARGX

767.6

+1.21%↑

SHL.DE

34.13

-0.32%↓

PHIA

23.38

+0.04%↑

FRE

39.68

+1.38%↑

SAN

73.44

+0.45%↑

ARGX

767.6

+1.21%↑

SHL.DE

34.13

-0.32%↓

PHIA

23.38

+0.04%↑

FRE

39.68

+1.38%↑

SAN

73.44

+0.45%↑

ARGX

767.6

+1.21%↑

SHL.DE

34.13

-0.32%↓

PHIA

23.38

+0.04%↑

FRE

39.68

+1.38%↑

Search

Fagron

Закрыт

СекторЗдравоохранение

24.15 1.9

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

24.15

Макс.

24.15

Ключевые показатели

By Trading Economics

Доход

-99K

45M

Продажи

-98K

476M

P/E

Средняя по отрасли

19.274

49.712

Дивидендная доходность

1.64

Рентабельность продаж

9.55

Сотрудники

4,193

EBITDA

11M

98M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+20.59% upside

Дивиденды

By Acuity

Дивидендная доходность

Средняя по отрасли

1.64%

2.36%

Следующий отчет о доходах

30 июл. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

123M

1.8B

Предыдущая цена открытия

22.25

Предыдущая цена закрытия

24.15

Новостные настроения

By Acuity

50%

50%

129 / 342 Рейтинг в Healthcare

Fagron График

Прошлые результаты не являются надежным индикатором будущих результатов.

О компании Fagron

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
help-icon Live chat